COMMUNIQUÉS West-GlobeNewswire

-
Adamis Pharmaceuticals Provides Update on U.S. Retail Launch of SYMJEPI
09/07/2019 -
Medtainer Inc. Announces Custom Orders from Planet 13
09/07/2019 -
AgraFlora Organics déploie sa technologie brevetée de bouchon distributeur de cannabinoïdes de qualité pharmaceutique dans un centre d'embouteillage certifié GMP de Toronto
09/07/2019 -
REPEAT - AgraFlora Organics Deploys Patented, Pharma-Grade Cannabinoid Delivery Bottle Cap Technology at GMP Certified Toronto, ON Bottling Facility
09/07/2019 -
CorMedix Receives Encouraging FDA Feedback on Neutrolin® LOCK-IT-100 Data
09/07/2019 -
California Tech Startup Ocutrx Vision Technologies Steals the Show at Prestigious Retina Conference
09/07/2019 -
Coloplast completes its SenSura® Mio ostomy care range with new innovative products for premature babies and kids
09/07/2019 -
Cognition Therapeutics Receives $3.3 Million NIA Grant to Conduct qEEG Study of Elayta™ with World-Leading Alzheimer’s Biomarker Experts
09/07/2019 -
TRHC and CQuentia Announce Collaboration to Leverage Scientific and Technology Resources to Provide Pharmacogenomic Services and Biometric Wearable Products to Patients and Providers
09/07/2019 -
Skin health startup Derm-Biome Pharmaceuticals, Inc. to receive funding from the Government of Canada
09/07/2019 -
BioDelivery Sciences Announces Further Improved Insurance Coverage for BELBUCA®
09/07/2019 -
Medical Research Council Funds Phase 2 Multi-Center Study of XBiotech’s Bermekimab in Advanced Cancer Patients
09/07/2019 -
Lutronic Vision to Present R:GEN™ Efficacy Data at 19th EURETINA Congress
09/07/2019 -
NICE Issues Draft Guidance on the Use of gammaCore for Cluster Headache
09/07/2019 -
CytomX Therapeutics Announces Second Target Selection and Program Initiation with AbbVie Under Ongoing, Multi-Program Strategic Oncology Collaboration
09/07/2019 -
GBT Announces New Employment Inducement Grants
09/07/2019 -
Immutep Raises A$10 Million Via Private Placement and Underwritten Entitlement Offer
09/07/2019 -
Inovalon Reaches Milestone and Achieves Integration With Epic
09/07/2019 -
ProMIS Neurosciences’ Data for Alzheimer’s Disease Clinical Candidate PMN310 Published in Scientific Reports
09/07/2019
Pages